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Calf pancreas microsomes were treated with OS-l% Triton X-100 and the resulting soluble enzyme 
preparation was incubated with GDP-D-[14C]mannose. The addition of synthetic Dol-PP derivative of the 
trisaccharide p-Man-( 1 - 4)-&GlcNAc-( 1 -4)GlcNAc stimulated the synthesis of labeled lipid-bound 
tetrasaccharide 50-lOO-fold. The labeled tetrasaccharide thus formed was identified as a-Man-(l-3)- 
&Man-(1 44)~,&GlcNAc-(l--r4)GlcNAc by its chromatographic properties and by its sensitivity to (Y- 
mannosidase and to endo-P-N-acetylglucosaminidase D. The solubilized cu-( 1 - 3)mannosyltransferase 
did not require divalent cation and was active in the presence of 10 mM EDTA. 
(I -+3)-D-Mannosyltransferase Dolichyl pyrophosphate Tetrasaccharide biosynthesis 
1. INTRODUCTION 
The major pathway for the biosynthesis of N- 
linked oligosaccharides in glycoproteins involves 
the transfer of a GlsMangGlcNAcz oligosac- 
charide from dolichyl pyrophosphate to protein. A 
scheme for the biosynthesis of this oligosac- 
+ Present address: McGill Cancer Centre, 3655 Drum- 
mond Street, Montreal, PQ H3G lY6, Canada 
Abbreviations: Dol-PP-trisaccharide, P’-dolichyl p-[O- 
,&8-D-mannopyranosyl-(1 - t4)-O-(2-acetamido-2-deoxy- 
B-D-glucopyranosyl)(1*4)-2-acetamido-2-deoxy-P-D- 
glucopyranosyllpyrophosphate; Dol-PP-tetrasaccharide, 
PI-dolichyl-p-[O-cY-D-mannopyranosyl-( l-+3)-0-& 
D-mannopyranosyl-( 1 --r4)-O-(2-acetamido-2-deoxy-fi- 
D-glucopyranosyl-( 1d4)-2-acetamido-2-deoxy-/3-D- 
glucopyranosyl] pyrophosphate; Dol-P-Man, dolichyl 
P-D-mannopyranosyl phosphate; Dol-P, dolichyl 
phosphate; BSA, bovine serum albumin 
charide, based upon the characterization of 
dolichol-linked oligosaccharides labeled in intact 
cells, has been proposed [l]. However, detailed 
knowledge of the enzymology of this pathway is 
still incomplete. Using synthetic dolichol 
derivatives as substrates we have characterized the 
3 enzymes involved in the biosynthesis of Dol-PP- 
trisaccharide containing a ,&mannose linked to di- 
N-acetylchitobiose [2-41. Here, we report the 
solubilization and partial characterization of the LY- 
(l -3)-D-mannosyltransferase from pancreas 
responsible for the formation of Dol-PP- 
tetrasaccharide from synthetic Dol-PP- 
trisaccharide and GDP-D-[‘4C]mannose. 
2. MATERIALS AND METHODS 
The source of chemicals has been described in 
[3]. The chemical synthesis of Dol-PP- 
trisaccharide and of the tetrasaccharide, a-D- 
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Man-p-( l -3)+3-D-Maw-( 1-4)~,&DGlcpNAc- 
(l-+4)-D-GlcNAc will be described separately 
(submitted). Endo-,&V-acetylglucosaminidase D
was purchased from Miles (Elkhart IN). Jack bean 
cu-mannosidase was obtained from Sigma (St Louis 
MO) and concanavalin A-Sepharose from Phar- 
macia (Piscataway NJ). 
2.1. Analytical methods 
Protein was estimated as in [5] using BSA as 
stansdard and carbohydrate was monitored with 
phenol/sulfuric acid [6]. Thin-layer chromatogra- 
phy (TLC) was performed on Merck precoated 
plates of silica gel G (0.25 mm thick, Merck, 
Darmstadt) in solvents: (A) chloroform/metha- 
nol/water (60 : 35 : 6, by vol.); and (B) chloroform/ 
methanol/water (10 : 10 : 3, by vol.). Compounds 
were detected on TLC with the anisaldehyde 
reagent [7]. Gel filtration was performed on a col- 
umn (1 x 110 cm) of Bio-Gel P-6 (200-400 mesh) 
in 0.1 M pyridine acetate buffer (pH 5.0) with 
bovine serum albumin to determine V, and D- 
mannose for Ve. Fractions of 1 ml were collected 
and assayed for radioactivity and carbohydrate. 
High pressure liquid chromatography (HPLC) was 
done with a Varian model 5000 apparatus using a 
Hibar EC column (4 mm x 250 mm) packed with 
5 pm Lichrosorb NH2 (EM Reagents, Gibbstown 
NJ). Acetonitrile/water (60: 40, v/v) pumped at 
1 ml/min was used for elution, and l-ml fractions 
were collected and assayed for radioactivity. 
Radioactivity was located on TLC with Kodak 
X-Omat R film, and was determined with a 
Packard liquid scintillation spectrometer, model 
3255 or an LKB Rackbeta, model 1218 using 
Hydrofluor (National Diagnostics, Somerville 
NJ), or Aquassure (New England Nuclear, Boston 
MA) for solutions, and Ready-Solv HP (Beckman, 
Fullerton CA) for TLC scrapings. 
2.2. Standard assay conditions 
Calf pancreas microsomes were prepared by 
method 2 as in [8] and kept frozen at - 80°C until 
use. The solubilized enzyme source was prepared 
by suspending the microsomes in 50 mM 
Tris-maleate buffer (pH 6.8) containing 1070 
Triton X-100, using a hand-driven Potter- 
Elvejehm homogenizer with a Teflon pestle; after 
standing in ice for l-2 h, the mixture was cen- 
trifuged for 1 h at 40000-50000 rev./min in a 
Beckman rotor 50 Ti. An aliquot (200 ~1) of the 
supernatant was then immediately incubated at 
37°C for 30 min in a total volume of 250,ul con- 
taining 0.05 &i GDP-D-[r4C]mannose (spec. act., 
269 mCi/mmol). Synthetic Dol-PP-trisaccharide 
was added to the incubation tube from a 
chloroform/methanol (2 : 1, v/v) solution, and the 
solvent was evaporated under a stream of N2 
before addition of the other components. At the 
end of the incubation, the products extracted with 
chloroform/methanol (2: 1, by vol.) and with 
chloroform/methanol/water (10 : 10 : 3, by vol.) 
were isolated as in 181. TLC of these lipid fractions 
was followed by radioautography and the radioac- 
tivity in Dol-PP-tetrasaccharide was estimated by 
scraping the appropriate area of silica gel. 
2.3. Preparation of labeled tetrasaccharide 
The labeled products in the lipid extracts were 
hydrolyzed with mild acid as in [4,8]. The 
hydrolysate was either chromatographed on a col- 
umn of Bio-Gel P-6, or was passed through coupl- 
ed columns (0.5 x 5 cm) of AG 5OW-X8 
(Hf-form, 200-400 mesh) and AG l-X8 (formate 
form, 200-400 mesh), concentrated and then frac- 
tionated by HPLC as above. 
2.4. Treatment with endo-b-N-acetyigiucos- 
aminidase D 
Labeled tetrasaccharide obtained by gel filtra- 
tion or by HPLC was mixed with 2OOpg of syn- 
thetic tetrasaccharide and incubated for 18 h at 
37°C in a total volume of 100 pl containing 0.05 M 
citrate/phosphate buffer (pH 6.0), 0.5 M NaCI, 
0.05% BSA, 25 pg cycloheximide, 25 /cg chloram- 
phenicol and 10 munits of endo-,&V- 
acetylglucosaminidase D. At the end of the incuba- 
tion the mixture was boiled for 3 min and the 
samples were chromatographed on Bio-Gel P-6. 
One-ml fractions were collected and assayed for 
radioactivity. Unlabeled carbohydrate was 
detected with the phenol/sulfuric acid reagent. 
2.5. Treatment with cu-mannosidase 
Labeled tetrasaccharide was incubated for 18 h 
at 37°C in a total volume of 100~1 containing 
0.01 M sodium acetate (pH 5.0), 0.025 M NaCI, 
0.02 mM ZnS04, 5% bovine serum albumin, 25 pug 
cycloheximide, 25 pg chloramphenicol and 1.4 
units of a-mannosidase. At the end of the incuba- 
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tion the mixture was boiled for 3 min and 
chromatographed on Bio-Gel P-6. 
3. RESULTS AND DISCUSSION 
When calf pancreas microsomes were incubated 
with GDP-D-[r4C]mannose, the addition of syn- 
thetic Dol-PP-trisaccharide greatly stimulated the 
incorporation of [‘4C]mannose into several lipid- 
bound oligosaccharides extracted with chloro- 
form/methanol (2 : 1, v/v) and chloroform/me- 
thanol/water (10: 10:3, by vol.). TLC of the 
chloroform/methanol extract in solvent A, and of 
the chloroform/methanol/water extract in solvent 
B showed that the labeling of several lipid-bound 
oligosaccharides was stimulated. The greatest 
stimulation was observed for the products with the 
fastest mobility on TLC, and the shortest oligosac- 
charides after mild acid hydrolysis. Addition of 
detergent (Triton X-100 or Nonidet P-40) greatly 
increased the extent of this stimulation; the maxi- 
mum effect was observed at concentrations of 
0.5-l .O%. Under these conditions, fewer products 
were formed, and about 85% of the enzyme activi- 
ty observed in the presence of synthetic Dol-PP-tri- 
saccharide was solubilized. 
Incubation of the soluble enzyme preparation 
with GDP-D-[‘4C]mannose followed by TLC of 
the chloroform/methanol extract showed that the 
addition of synthetic Dol-PP-trisaccharide sti- 
mulated by 50-lOO-fold the formation of a major 
product with &,l_P_Man of about 0.2 (fig.1). In 
some experiments, but not in all cases, the forma- 
tion of Dol-P-Man was also greatly stimulated by 
the addition of synthetic Dol-PP-trisaccharide, 
possibly because of degradation of the latter to 
Dol-P. 
Upon mild acid treatment (0.1 M HCl at 90°C 
for 30 min) the labeled glycolipid (compound B in 
fig. 1) yielded a labeled oligosaccharide which was 
not retained on concanavalin A-Sepharose and 
which had the same chromatographic mobility 
(Rr = 0.1) on TLC in solvent B, and the same elu- 
tion profile from Bio-Gel P-6 (fig.2) as the syn- 
thetic tetrasaccharide, a-Man-( 1 - 3)-&Man- 
(l-+4)-@-GlcNAc-( l -4)GlcNAc. Treatment of 
the labeled tetrasaccharide with cY-mannosidase 
released all the labeled mannose, and incubation 
with endo-&ZV-acetylglucosaminidase D resulted in 
the formation of a labeled product which was 
300 
Fig. 1. TLC of chloroform/methanol (2 : 1, v/v) extract 
in solvent A. Incubation of the solubilized preparation 
with GDP-D-[r4C]mannose was performed under 
standard conditions with: (1) no addition; (2) 40 pg/ml 
Dol-PP-trisaccharide; (3) 10 mM EDTA; (4) 4Olg/ml 
Dol-PP-trisaccharide and 10 mM EDTA; (5) 40pg/ml 
Dol-PP-trisaccharide and 10 mM MnClz; (6) 10 mM 
MnC12. Radioautography of the TLC was obtained after 
4 days of exposure: (0) origin; (F) solvent front; (A) 
Dol-P-Man; (B) Dol-PP-tetrasaccharide. 
eluted with a-Man-( l -3)-&Man-( l-4)- 
GlcNAc; the latter compound was obtained by 
endo-fi-!V-acetylglucosaminidase D treatment of 
the synthetic tetrasaccharide (fig.2). Since endo-& 
N-acetylglucosaminidase D has a specific require- 
ment for the presence of a terminal a-1,3-linked 
mannose residue attached to the &linked mannose 
[9], these results demonstrate that the labeled 
tetrasaccharide has the structure, a-D-Man- 
p( 1 - 3)-P-D-Manp-( l-4)-&GlcpNAc- 
(l -4)-D-GlcNAc. 
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Fig.2. Effect of cr-mannosidase and endo-B-N- 
acetylglucosaminidase D. Labeled tetrasaccharide mixed 
with synthetic tetrasaccharide was chromatographed on 
Bio-Gel P-6 before (o---o) and after treatment with CY- 
mannosidase (A---A) or with endo-&N-acetyl- 
glucosaminidase D (w) as in section 2. The 
positions of (1) Mannose, (3) cu-Man-(1-+3)-B- 
Man( 1 --r4)-GlcNAc, (4) a-Man-( l-3)-& 
Man( 1-4)~&GlcNAc, are indicated. 
The formation of the labeled Dol-PP- 
tetrasaccharide was proportional to the concentra- 
tion of synthetic Dol-PP-trisaccharide in the 
medium (fig.3), and was time-dependent for about 
30 min incubation at 32 Pg Dol-PP- 
trisaccharide/ml (fig.4). The addition of Mn2+ in- 
hibited the synthesis of the tetrasaccharide-lipid, 
presumably because the formation of Dol-P-Man 
and of other lipid-bound oligosaccharides was 
enhanced in the presence of divalent cation (fig. 1). 
Furthermore, the synthesis of Dol-PP- 
tetrasaccharide was observed in the presence of 
10 mM EDTA; under these conditions Dol-P-Man 
synthesis was completely inhibited (fig. 1). These 
results indicate that the cu-(1-3)-D- 
mannosyltransferase from pancreas has no re- 
quirement for divalent cation, in direct contrast to 
the (u-( l -6)-D-mannosyltransferase from the 
same tissue (submitted). It is also different from 
the liver a-( 1 - 3)-D-mannosyltransferase 
described in [lo]. The latter enzyme required 
divalent cation for optimum activity and was 
greatly inhibited by as low as 0.1% detergent. The 
reasons for the different properties of the liver and 
pancreas a-( l-3)-D-mannosyltransferases are 
not clear, but it should be pointed out that the 
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Fig.3. Effect of synthetic Dol-PP-trisaccharide 
concentration on labeling of Dol-PP-tetrasaccharide 
from GDP-D-[‘“Clmannose. The soluble enzyme 
preparation was incubated with GDP-D-[14C]mannose 
under standard conditions, but with different 
concentrations of synthetic Dol-PP-trisaccharide as 
indicated. At the end of the incubation, the 
chloroform/methanol extract was chromatographed in 
solvent A and the radioactivity corresponding to Dol- 
PP-tetrasaccharide was located by radioautography and 
estimated by scraping the appropriate area. 
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Fig.4. Time course of Dol-PP-tetrasaccharide synthesis. 
The soluble enzyme preparation was incubated for 
different periods of time under standard conditions with 
32 /rg/ml synthetic Dol-PP-trisaccharide. The 
incorporation of radioactivity from GDP-D- 
[14C]mannose into Dol-PP-tetrasaccharide was 
determined after TLC as described in fig.3. 
301 
Volume 156, number 2 FEBS LETTERS June 1983 
substrate used for the characterization of the liver 
enzyme was a mixture of tetrasaccharide-lipids 
with both a-(1-3)- and cu-(l-6)-mannose 
residues attached to the P-D-mannose residues, 
and although the liver mannosyltransferase activi- 
ty was partially purified, the preparation still con- 
tained both a-(1 -3)- and a-(1+6)-D- 
mamrosyltransferase activities. The (u-( 1 - 3)- 
mannosyltransferase described here is likely to be 
the enzyme responsible for the biosynthesis of 
dolichyl pyrophosphate tetrasaccharide according 
to the scheme proposed in [l]. 
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